Immediate Evaluation for Iatrogenic Anticholinergic Exposure
The most likely cause of bilateral mydriasis and insomnia in a 2-year-old immediately following an ED visit is inadvertent exposure to anticholinergic medications, most commonly mydriatic eye drops (cyclopentolate, tropicamide, atropine) or nebulized ipratropium bromide, and this requires immediate recognition as a benign, self-limited condition that typically resolves within 24-48 hours without intervention 1, 2.
Critical First Steps
Obtain a detailed medication history from the ED visit focusing specifically on:
- Ophthalmic drops administered (cyclopentolate causes anticholinergic syndrome in children even at therapeutic doses) 1
- Nebulized bronchodilators (ipratropium can cause mydriasis if mask fit was poor, allowing medication contact with eyes) 2
- Any topical medications or patches applied
- Accidental exposure to parents' medications or eye drops
Clinical Assessment
Examine for the complete anticholinergic toxidrome:
- Bilateral vs unilateral mydriasis (bilateral suggests systemic absorption; unilateral suggests direct ocular contact)
- Pupillary light reflex (absent or sluggish)
- Skin findings: flushed, dry skin
- Mucous membranes: dry mouth
- Mental status: agitation, confusion, inability to recognize family members, incoherent speech 1
- Vital signs: tachycardia, hyperthermia
- Urinary retention
Diagnostic Approach
No laboratory testing or neuroimaging is required if the clinical picture is consistent with anticholinergic exposure and the child has normal mental status or only mild agitation 1. The diagnosis is purely clinical.
However, you must rule out life-threatening causes if:
- Unilateral mydriasis with altered mental status (consider increased intracranial pressure, uncal herniation) 2
- Severe agitation or obtundation
- Focal neurological deficits
- History of significant head trauma
Management Algorithm
For mild-to-moderate anticholinergic syndrome:
- Supportive care only
- Discontinue offending agent
- Observation for 4-6 hours
- Reassurance to parents that complete resolution occurs within 24-48 hours 1, 2
- No antidote (physostigmine) needed unless severe symptoms present
For severe anticholinergic syndrome (severe agitation, hyperthermia >40°C, seizures, hemodynamic instability):
- Consider physostigmine administration (requires cardiorespiratory monitoring)
- ICU admission may be necessary
Addressing the Insomnia Component
The sleep disturbance is part of the anticholinergic syndrome and will resolve as the medication clears 1. Do not initiate sleep medications. Provide supportive measures:
- Quiet, dark environment
- Parental presence for reassurance
- Avoid additional sedating medications that could complicate the clinical picture
Common Pitfalls
- Over-investigation: Ordering unnecessary CT scans, toxicology screens, or extensive metabolic panels when history clearly points to iatrogenic exposure 3
- Missing the exposure history: Not specifically asking about eye drops or nebulizers from the ED visit
- Misdiagnosing as neurological emergency: Unilateral mydriasis from ipratropium can mimic uncal herniation, but the child will be well-appearing otherwise 2
- Premature discharge: Observe until mental status normalizes and parents understand the benign, self-limited nature
Expected Timeline
- Peak symptoms: 1-4 hours post-exposure
- Mydriasis resolution: 24-48 hours (can persist up to 72 hours with cyclopentolate) 1
- Sleep normalization: Within 24-48 hours as anticholinergic effects wane
If symptoms persist beyond 48-72 hours or worsen, reconsider the diagnosis and evaluate for alternative etiologies including ingestion, metabolic disorders, or neurological pathology 3.